Wed. 13 Mar 2024, 7:39am ET
Benzinga
Earnings, News
Indaptus Therapeutics (NASDAQ:INDP) reported quarterly losses of $(1.83) per share which beat the analyst consensus estimate of $(1.95) by 6.15 percent. This is a 5.78 percent decrease over losses of $(1.73) per share from the same period last year.